Catamaran Corp (USA)  

(Public, NASDAQ:CTRX)   Watch this stock  
Find more results for NASDAQ:SXCI
47.25
-0.03 (-0.06%)
Aug 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 47.07 - 47.75
52 week 36.98 - 56.79
Open 47.32
Vol / Avg. 816,016.00/1.38M
Mkt cap 9.81B
P/E 34.66
Div/yield     -
EPS 1.36
Shares 207.41M
Beta 0.27
Inst. own 88%
Oct 29, 2014
Q3 2014 Catamaran Corp Earnings Release (Estimated) - 6:00AM EDT - Add to calendar
Aug 1, 2014
Q2 2014 Catamaran Corp Earnings Call
Aug 1, 2014
Q2 2014 Catamaran Corp Earnings Release
Jun 10, 2014
Catamaran Corp at Goldman Sachs Healthcare Conference
Jun 3, 2014
Catamaran Corp at Jefferies Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 1.60% 2.02%
Operating margin 2.51% 3.00%
EBITD margin - 4.66%
Return on average assets 3.86% 3.88%
Return on average equity 5.70% 5.51%
Employees 4,000 -
CDP Score - -

Address

1600 MCCONNOR PARKWAY
SCHAUMBURG, IL 60173-6801
United States - Map
+1-800-2823232 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Catamaran Corporation (Catamaran), formerly SXC Health Solutions Corp., is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company�s product offerings and solutions combine a range of applications and PBM services designed to assist its customers in reducing the cost and managing the complexity of their prescription drug programs. The Company�s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third party health care plan administrators, and state and federal government entities. In January 2012, the Company completed its acquisition of HealthTran LLC (HealthTran). On July 2, 2012, the Company acquired Catalyst Health Solutions, Inc. On October 1, 2013, the Company acquired RESTAT, LLC.

Officers and directors

Mark A. Thierer Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Mike Shapiro Chief Financial Officer, Senior Vice President
Age: 43
Bio & Compensation  - Reuters
Jeffrey Park Executive Vice President - Operations
Age: 42
Bio & Compensation  - Reuters
John Romza Executive Vice President - Quality and Innovation
Age: 58
Bio & Compensation  - Reuters
Joel Saban Executive Vice President - Pharmacy Operations
Age: 46
Bio & Compensation  - Reuters
Clifford E. Berman Senior Vice President, General Counsel, Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Steven D. Cosler Lead Independent Director
Age: 58
Bio & Compensation  - Reuters
Peter J. Bensen Independent Director
Age: 51
Bio & Compensation  - Reuters
William J. Davis Independent Director
Age: 46
Bio & Compensation  - Reuters
Steven B. Epstein J.D. Independent Director
Age: 70
Bio & Compensation  - Reuters